Oakwood Medical Investors
Search |
Home
About Us
Management Team
Physician Venture Partners
Advisory Committee
Funds
Oakwood Investors I
Oakwood Medical Investors II
Oakwood Medical Investors III
Oakwood Medical Investors IV
Oakwood Medical Investors V
News
Contact Us
Contact Information
Submit Business Plan
News Detail
TransMolecular Announces Presentation of Data Highlighting Anti-angiogenic and Tumor-targeting Properties of TM601 at ASCO Annual Meeting
21 May 2009
by:
Read the article
|
Contact Us
Site Map
Privacy Policy
Site Credits
Copyright © 2007 Oakwood Medical Investors